UPDATE : Monday, September 7, 2020
상단여백
‘Government should control next-generation sequencing data’
About three years have passed since the Korean government started to grant ...
by Kim Yun-mi  |  2020-01-20 15:47
라인
Pfizer’s spinoff of generics unit causes disputes with trade union
Pfizer’s spinoff of its generics business division has made the employment ...
by Kim Yun-mi  |  2020-01-20 15:44
라인
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
People with ulcerative colitis and Crohn’s disease who have failed with sta...
by Kim Yun-mi  |  2020-01-17 17:30
라인
GSK to target ovarian cancer, multiple myeloma, endometrial cancer
After entering the oncology market with the acquisition of Tesaro in late 2...
by Kim Yun-mi  |  2020-01-16 14:10
라인
Regulator to mandate long-term follow-up on advanced biopharmaceuticals
“A fast-track review and mandating a long-term follow-up study will be the ...
by Kim Yun-mi  |  2020-01-15 13:05
라인
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
MSD is expected to announce the results of a study, whether Steglatro (ingr...
by Kim Yun-mi  |  2020-01-14 15:28
라인
Zejula widens indication as monotherapy for ovarian cancer
Takeda’s PARP (poly ADP-ribose polymerase) inhibitor Zejula (ingredient: ni...
by Kim Yun-mi  |  2020-01-13 16:25
라인
Lilly secures atopic dermatitis drug through Dermira acquisition
Lilly has enhanced its immune disease pipelines by obtaining the rights to ...
by Kim Yun-mi  |  2020-01-13 14:05
라인
Latecomer Bavencio improves overall survival in bladder cancer trial
Bavencio (ingredient: avelumab), a latecomer in the Tecentriq-led immune ch...
by Kim Yun-mi  |  2020-01-10 14:23
라인
Regulator to help Korean firms’ global biz through international cooperation
The Ministry of Food and Drug Safety will push for utilizing artificial int...
by Kim Yun-mi  |  2020-01-08 16:33
라인
Eliquis price cut delayed amid prolonged administrative suit
The Ministry of Health and Welfare’s order in June to cut the price of BMS ...
by Kim Yun-mi  |  2020-01-07 11:32
라인
BioMarin seeks license for gene therapy to treat hemophilia
The world might be one step closer to the eradication of hemophilia.BioMari...
by Kim Yun-mi  |  2020-01-06 16:44
라인
Tau, rather than amyloid, may cause Alzheimer’s disease
After a recent study suggested that researchers advocating the “amyloid hyp...
by Kim Yun-mi  |  2020-01-06 14:13
라인
[New Year Special] Investors vulnerable to risky biotech business
President Moon Jae-in announced in May that the government would designate ...
by Kim Yun-mi  |  2020-01-02 17:35
라인
Multinational pharmaceuticals' rush to merge face union backlash in Korea
Large multinational pharmaceutical companies have recently announced acquis...
by Kim Yun-mi  |  2019-12-29 10:54
라인
‘No-Japan’ campaign cause anxiety among Japanese pharmaceutical firms
During this year, Japan's export restrictions led to a nationwide boyco...
by Kim Yun-mi  |  2019-12-27 12:08
라인
Migraine drug market heats up with Ubrelvy’s arrival
After Lilly’s acute migraine drug Reyvow (ingredient: lasmiditan) obtained ...
by Kim Yun-mi  |  2019-12-27 11:57
라인
Dupixent to get coverage from January
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi  |  2019-12-24 15:40
라인
‘Korea still slow to expand benefit for new drugs’
Avi Ben-Shoshan, chairman of the Korea Research-based Pharma Industry Assoc...
by Kim Yun-mi  |  2019-12-24 15:37
라인
Vitamin E acetate likely cause of lung injuries from vaping
Vitamin E acetate was associated with lung injuries in people who smoked el...
by Kim Yun-mi  |  2019-12-23 15:02
여백
여백
여백
Back to Top